We have recently shown through isoform-specific knockdown analyses and with isoform-specific pharmacologic inhibitors that the activity of PI3K, and specifically of the isoform p110α, is primarily required to maintain intrinsic Akt activation in MM cell lines [15]. This evidence concerns the gene AKT1 and Miyoshi myopathy.